Sobi Update regarding Sanfilippo Type A clinical trial

June 27, 2019

The following letter was released by Sobi on June 24, 2019, regarding its enzyme-replacement therapy clinical trial for Type A.

We continue to communicate and collaborate with the company about the future of the trial, in an effort to continue to help children with Sanfilippo. 

Related Posts

ADVANCE 2026 conference recordings available

Oct 12, 2026

Recorded Sessions Available for On-Demand Replay The world of Sanfilippo Syndrome is changing fast. New research. New ideas. New possibilities. ADVANCE 2026 is your chance to get caught up on what’s happening and focus in on the topics you want to know more about. The...

NGT-104 AAV9 Gene Therapy | MPS IIIB | Phase I-II | NeuroGT

Sep 25, 2026

Page last updated: October 5, 2026 Page reviewed by: Dr. Cara O'Neill, FAAPFor web accessibility options: Click/tap the floating blue icon on the right.Clinical Trial Summary The goal of this clinical trial is to learn if one infusion of NGT-104 (rAAV9-CMV-hNAGLUop)...